
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Gα o CRISPR/Cas9 KO Plasmid (h) | sc-400897 | 20 µg | $397.00 |
GNAO1 encodes the human heterotrimeric G protein alpha subunit Gαo, a dominant Gi/o-family signaling component enriched in neurons that couples activated GPCRs to inhibition of adenylyl cyclase and modulation of ion channels. Through regulation of cAMP/PKA signaling, Ca2+ and K+ channel activity, and downstream MAPK and neurotransmitter release pathways, Gαo shapes synaptic transmission, neuronal excitability, and network development. Altered GNAO1 function is linked to neurodevelopmental and movement disorder phenotypes, making it a key node for interrogating GPCR-driven signaling architecture in cellular and neuronal models. Experimental disruption of GNAO1 supports mechanistic studies of receptor coupling specificity, second-messenger dynamics, and activity-dependent transcriptional responses.
Gα o CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the GNAO1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the GNAO1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the GNAO1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Gα o protein expression.
This CRISPR knockout system enables efficient generation of GNAO1-deficient cell models for investigation of Gα o signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.